Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 8;12(8):e12177. doi: 10.1002/clt2.12177

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Immunological characterization of rPru du 1. (A) Specific IgE to almond extract and rPru du 1 of sera from 17 almond allergic patients and correlation between sIgE levels to rPru du 1, almond extract and rBet v 1 in almond allergic patients (Spearman correlation). (B) IgE inhibition ELISA. Sera were inhibited with increasing concentrations of rBet v 1 (0.0001–10 μg/ml) and rPru du 1 (0.001–100 μg/ml). Horizontal bars indicate medians ± interquartile ranges. Inhibitions with other allergens were performed at 10 μg/ml. *Inh. conc.: Inhibitor concentration. (C) Basophil activation assay with RS‐ATL8 rat basophil leukemia (RBL) cells sensitized with sera from 14 patients (Table S1)